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ABSTRACT
Background
Increasing evidence supporting the value of screening women for cervical cancer once in
their lifetime, coupled with mounting interest in scaling up successful screening demonstration
projects, present challenges to public health decision makers seeking to take full advantage of
the single-visit opportunity to provide additional services. We present an analytic framework for
packaging multiple interventions during a single point of contact, explicitly taking into account
a budget and scarce human resources, constraints acknowledged as significant obstacles for
provision of health services in poor countries.
Methods and Findings
We developed a binary integer programming (IP) model capable of identifying an optimal
package of health services to be provided during a single visit for a particular target population.
Inputs to the IP model are derived using state-transition models, which compute lifetime costs
and health benefits associated with each intervention. In a simplified example of a single
lifetime cervical cancer screening visit, we identified packages of interventions among six
diseases that maximized disability-adjusted life years (DALYs) averted subject to budget and
human resource constraints in four resource-poor regions. Data were obtained from regional
reports and surveys from the World Health Organization, international databases, the published
literature, and expert opinion. With only a budget constraint, interventions for depression and
iron deficiency anemia were packaged with cervical cancer screening, while the more costly
breast cancer and cardiovascular disease interventions were not. Including personnel
constraints resulted in shifting of interventions included in the package, not only across
diseases but also between low- and high-intensity intervention options within diseases.
Conclusions
The results of our example suggest several key themes: Packaging other interventions during
a one-time visit has the potential to increase health gains; the shortage of personnel represents
a real-world constraint that can impact the optimal package of services; and the shortage of
different types of personnel may influence the contents of the package of services. Our
methods provide a general framework to enhance a decision maker’s ability to simultaneously
consider costs, benefits, and important nonmonetary constraints. We encourage analysts
working on real-world problems to shift from considering costs and benefits of interventions
for a single disease to exploring what synergies might be achievable by thinking across disease
burdens.
The Editors’ Summary of this article follows the references.
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Although substantial public health efforts are directed
toward improving the health and birth outcomes of pregnant
women [1], nearly two-thirds of healthy years lost by women
in developing countries are caused by problems other than
reproductive health [2]. A disease that is particularly relevant
to women in developing countries is cervical cancer, which
remains a leading cause of cancer death [3]. Cervical cancer is
preventable by identifying (by Pap smears) and treating
precancerous lesions before they progress to cancer. Mortal-
ity from this cancer has been reduced in countries able to
sustain cervical screening programs, but these kinds of
programs have been difﬁcult to implement in poor countries
because of the laboratory and technical expertise required,
the multiple visits required for screening, diagnosis, and
treatment, and the need for repeated screening at regular
intervals. There is increasing evidence that cervical cancer
screening once or twice between ages 35 and 45 years, using
screening tests that both require less technical expertise and
can be embedded in strategies that enhance the linkage
between screening and treatment, would be beneﬁcial to the
health of patients, cost-effective, and feasible [4–8].
For countries considering the introduction of single
lifetime screening strategies, the point of contact between a
woman and the health care system during the screening visit
represents an opportunity to offer other health interventions,
increasing access to essential services, and reducing patient
time and travel costs. The design of such a package of services
requires careful consideration of both the potential health
gains achievable with different interventions and the resour-
ces available to support them. Although an obvious constraint
is the monetary resources available to fund health programs,
the shortage of human resources is increasingly acknowl-
edged as an even more formidable obstacle [9–11].
While other analyses have evaluated the costs and beneﬁts
of packaging health services in developing country settings
[12], none have incorporated resource constraints other than
the lack of funds. Motivated by the momentum associated
with the international interest in single lifetime cervical
cancer screening strategies, we developed an analytic frame-
work to identify an optimal package of health services that
explicitly takes into consideration both monetary and human
resource constraints. We demonstrate this framework by
presenting a simpliﬁed example, which includes a select
group of diseases, interventions, and constraints that are
relevant among women in four resource-poor regions of the
world.
Methods
Analytic Overview
We developed a binary integer programming (IP) model
capable of identifying an optimal package of health services
to be provided during a single visit for a particular target
population. We selected an IP model to make the explicit
assumption that a chosen intervention must cover all
eligible individuals. Inputs to the IP model are derived
using state-transition models, which simulate the effects of
an intervention on the natural history of disease and
compute lifetime costs and health beneﬁts associated with
each intervention. The IP algorithm considers all possible
combinations of interventions and identiﬁes the package of
services that simultaneously satisﬁes the objective function
(e.g., maximize health beneﬁts) while adhering to the
speciﬁed constraints. The binary aspect requires that
interventions are either fully implemented (1) or not
implemented at all (0).
Data Requirements and Synthesis
Data on incidence, prevalence, and mortality for each
health condition are synthesized using state-transition mod-
els. Individuals enter each disease-speciﬁc model at a
particular age, transition through a series of health states
reﬂecting the natural history of each disease, and face
competing mortality rates from other causes. For each
disease, multiple competing choice interventions with differ-
ent levels of complexity, effectiveness, and costs may be
considered. Depending on the perspective of the analysis,
relevant costs are included in the model; for example, with a
health systems perspective, direct medical costs associated
with each intervention option would be included. Data on the
effectiveness of screening and/or treatment are entered into
the model. The models are then used to generate estimates of
the average per-woman lifetime costs and health outcomes
associated with each intervention option. Disease-speciﬁc
outcomes are translated into standardized measures of lost
years of healthy life, expressed as disability-adjusted life years
(DALYs) [13]. DALYs include both years of life lost due to
premature mortality and years lived in less than perfect
health, adjusted for severity using a ‘‘disability weight’’ that
can range from 0 (no disability) to 1 (complete disability).
DALYs are estimated with and without the intervention, and
the difference between the two measures represents the
DALYs averted by the intervention.
In order to account for human resource requirements, we
considered the personnel time required for the main initial
visit at which women receive the package of services, as well
as for follow-up diagnostic procedures for women who
require them. Providers can be differentiated by level of
training, education, and availability, such as ‘‘specialized’’ to
indicate personnel with advanced skills or training (e.g.,
physicians and laboratory specialists), or ‘‘general’’ to
indicate those with less specialized training (e.g., nurse
midwives and auxiliary medical staff).
IP Model
As shown in Figure 1, the IP model consists of the objective
function, which maximizes DALYs averted through the health
interventions (equation 1), the constraint of choosing no
more than one intervention option per disease (equation 2), a
budget constraint, expressed as a per-woman lifetime health
expenditure (equation 3), and human resource constraints,
limiting the available general (equation 4a) and specialized
(equation 4b) personnel time separately.
A Simplified Example
In order to demonstrate how one might synthesize data and
conduct such an analysis, we elected to present a simpliﬁed
example using our motivation for leveraging single lifetime
cervical cancer screening to package other health services.
We recognize and emphasize to the reader that the full set of
data required for a comprehensive policy analysis were not
available, but that we use this example to serve as a
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Packaging Health Servicespedagogical tool and an application of the methods. It is
important to note that provision of an intervention in a
single visit refers to the delivery of the initial component of
the intervention (e.g., screening test) but does not require
that the follow-up of the identiﬁed subset of patients who
require subsequent treatment occur in that same visit (see
details below, and in Text S1).
Our target population was women between the ages of 35
and 40 years in four regions of the world with the highest
burden of diseases and the highest child and adult mortality
rates [2]. As categorized by the World Health Organization
(WHO), these included Africa (AFR-D,E), Americas (AMR-D),
Eastern Mediterranean (EMR-D), and Southeast Asia (SEAR-
D). The designations D and E refer to WHO mortality strata
that deﬁne states within the accompanying countries or
regions; D indicates states with high child mortality and high
adult mortality, and E indicates states with high child
mortality and very high adult mortality. Future studies may
contextualize the analysis to the regional, country, or clinic
level, provided data are available.
In addition to cervical cancer, we chose ﬁve health
conditions that affect women after their childbearing years,
and for which data on burden of disease were available from
the published literature (Table 1) [2]. These additional health
conditions included breast cancer, cardiovascular disease
(CVD), depression, iron deﬁciency anemia, and sexually
transmitted diseases (STDs, excluding HIV). In this example,
we excluded diseases already being targeted by major
initiatives, such as AIDS, tuberculosis, and malaria [14].
Based on the best available data, we included two
intervention options for each disease (Table 2). In general,
the more costly of the two was more effective and more
technically complex to provide examples of interventions
with differing levels of intensity. These particular interven-
tions were selected because of the evidence of potential
efﬁcacy in the population of interest [15–28]. It is worth
noting that we knowingly included interventions that have
conventionally not been provided at a single point in time
(e.g., breast cancer screening). This choice was made in part
because published efﬁcacy data for alternative interventions
targeted to women in this age group were limited, and in part
because the nature of our example is intended to serve as a
demonstration of the methods. Models were constructed
using TreeAge Pro software (Williamstown, Massachusetts,
United States), and all costs were expressed in 2001 interna-
tional dollars ($) to allow for comparisons across regions. We
approximated the personnel time required for the main
initial visit and for follow-up diagnostic procedures on the
basis of evidence from the literature and expert opinion.
Further details of model inputs and assumptions, interven-
tion costs and effects, and personnel time requirements are
included in Text S1. Table 3 shows the per-woman lifetime
costs and DALYs averted estimated by the models by
intervention and region.
In keeping with the motivation outlined in our introduc-
tion, we included an additional constraint of a mandatory
cervical cancer screen at age 40 (see Text S1 for
corresponding IP model equations). We set our initial
budget to $75 per woman, based on the annual health care
expenditure of $5 per capita in the poorest countries [30],
presuming that this single lifetime visit was targeted to
women only once within two decades following their
reproductive years and discounting future costs at 3% per
year. Because we lacked region-speciﬁc data on available
personnel time, for each type of personnel we calculated the
time required for each disease, which was averaged between
the low- and high-intensity intervention options. Constraints
were expressed as fractions of the total amounts of general
and specialized personnel times required to implement one
intervention for each disease. In this particular example, we
applied an arbitrary constraint of 50% on both general and
specialized personnel times, and then on specialized person-
nel time only to explore the inﬂuence of relative availability
Figure 1. Equations of the Integer Programming Model
The IP model consists of the objective function, which maximizes DALYs
averted through the health interventions (equation 1); the constraint of
choosing no more than one intervention option per disease (equation 2);
a budget constraint, expressed as a per-woman lifetime health
expenditure (equation 3); and human resource constraints, limiting the
available general (equation 4a) and specialized (equation 4b) personnel
time separately.
doi:10.1371/journal.pmed.0030434.g001
Table 1. Percent Burden of Disease among Women Aged 30–59
Years Attributable to Selected Conditions
Disease/Condition Burden (%)
AFR-D,E AMR-D EMR-D SEAR-D
Breast cancer 1.0 2.3 2.0 1.3
Cervical cancer 1.1 2.7 1.1 1.4
Cardiovascular disease 9.9 8.6 13.2 13.5
Depression 4.0 12.7 9.6 11.4
Iron deficiency anemia 0.8 2.3 1.2 2.7
STDs (excluding HIV) 1.0 0.4 0.8 1.0
Total 17.7 29.1 27.9 31.2
The percent burden of disease was calculated using data from the 2002 World Health
Report [2] as the proportion of the total number of DALYs attributable to each disease
among women aged 30–59 years.
doi:10.1371/journal.pmed.0030434.t001
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Packaging Health Servicesamong different personnel types. We also explored the
implications of changing the budget.
Results
Table 4 shows the selection of interventions from our
example of a one-time cervical cancer screening visit under
different sets of constraints. When we constrained only the
budget, interventions for cervical cancer, depression, and
iron deﬁciency anemia were included in all four regions,
while interventions for breast cancer and CVD were not
(results for budget-only constraint). In AFR-D,E and SEAR-
D, PCR testing for sexually transmitted diseases was also
selected for the package. With the exception of hemoglobin
testing for iron deﬁciency in AMR-D, the more costly option
for each disease-speciﬁc intervention was chosen.
When we introduced a 50% shortage of both general and
specialized personnel time (results on budget with all
Table 3. Total Per-Woman Lifetime Costs and DALYs Averted
Targeted
Disease
Intervention AFR-D,E Costs
a
(DALYs Averted)
AMR-D Costs
a
(DALYs Averted)
EMR-D Costs
a
(DALYs Averted)
SEAR-D Costs
a
(DALYs Averted)
Breast cancer CBE 17.50 (0.00066) 13.60 (0.00089) 14.50 (0.00086) 11.10 (0.00090)
Mammography 30.60 (0.00087) 30.90 (0.00117) 33.60 (0.00113) 25.40 (0.00119)
Cervical cancer VIA 41.90 (0.04780) 45.70 (0.06660) 46.10 (0.06050) 39.30 (0.05790)
HPV DNA test 51.10 (0.05900) 58.50 (0.08260) 59.10 (0.07480) 50.80 (0.07150)
CVD BP measurement 28.20 (0.01480) 32.30 (0.01910) 29.80 (0.01460) 28.20 (0.01290)
Triple therapy for all 76.20 (0.03500) 86.00 (0.04520) 80.70 (0.03440) 76.30 (0.03030)
Depression TCA 3.70 (0.00368) 5.10 (0.00503) 4.20 (0.00492) 3.80 (0.00530)
SSRI 11.20 (0.00490) 13.00 (0.00671) 11.80 (0.00656) 11.50 (0.00707)
Iron deficiency anemia Hemoglobin test 2.50 (0.00186) 2.90 (0.00232) 2.70 (0.00220) 2.80 (0.00214)
Iron for all 3.40 (0.00264) 3.50 (0.00328) 2.90 (0.00311) 3.20 (0.00303)
STDs Syndromic management 2.40 (0.00015) 2.40 (0.00017) 1.70 (0.00017) 1.90 (0.00016)
PCR assay 4.10 (0.00027) 4.10 (0.00028) 4.10 (0.00029) 4.10 (0.00027)
Total DALYs averted were calculated compared to no intervention.
aAll costs are expressed in 2001 international dollars ($) to allow for comparison across regions. Direct medical costs included the costs of screening, diagnosis, and treatment of suspected
cases, drugs, and staff time. Cost of the primary health care visit at initial screening was included only with the cervical cancer intervention, since all other interventions, if chosen as part of
the package, would occur at the same visit. Costs were discounted at a rate of 3% per year only in the case of CVD treatment, since all other interventions occur within one year. All future
DALYs were discounted at a rate of 3% per year, based on recommendations from the Panel on Cost-Effectiveness [29].
BP, blood pressure; CBE, clinical breast exam; PCR, polymerase chain reaction; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant; VIA, visual inspection using acetic
acid.
doi:10.1371/journal.pmed.0030434.t003
Table 2. Selected Interventions
Targeted
Disease
Intensity Screening
(Sensitivity, %
Specificity, %)
Diagnosis/
Treatment
General Personnel
Time (min)
a
Specialized
Personnel
Time (min)
a
Breast cancer Low Clinical breast exam (54/94) Diagnostic biopsy/stage-specific treatment
b 10 2
High Mammogram (71/93) Diagnostic biopsy/stage-specific treatment
b 25 13
Cervical cancer Low VIA (68/85) Diagnostic biopsy/stage-specific treatment
b 20 6
High HPV DNA test (84/88) Diagnostic biopsy/stage-specific treatment
b 15 21
CVD Low BP measurement (56/63)
c Triple drug therapy
d 50
High None Treat all with triple drug therapy
d 20
Depression Low Questionnaire (98/75)
e TCA 20 0
High Questionnaire (98/75)
e SSRI 20 0
Iron deficiency anemia Low Hemoglobin test (71/95) Iron supplements 10 5
High None Treat all with iron supplements 2 0
STDs Low Syndromic management (73/55)
f Doxycycline and ciprofloxacin 10 0
High PCR assay of cervical sample (95/95) Doxycycline and/or ciprofloxacin 10 5
Interventions were loosely classified as low- or high-intensity options. The screening phase involved an initial screening test for all women; some women required additional diagnosis
and/or treatment that occurred either at the same visit or at subsequent visits within the course of one year, except for CVD treatment, which occurred for 5 years. See Text S1 for further
details. Data on screening sensitivity and specificity were obtained from the published literature [15–28].
aTime estimates for each procedure are for one woman and reflect time required for the initial screen and time for diagnostic procedures (weighted by the proportion of women who
undergo further follow-up). Further details are presented in Table B in Text S1.
bStage-specific treatment includes surgery and/or radiotherapy.
cTest characteristics for blood pressure screen reflect detection of presence (sensitivity) or absence (specificity) of future CVD event.
dTriple drug therapy consists of beta-blockers, statins, aspirin.
eAll women are screened using a questionnaire (Composite International Diagnostic Interview Short Form [23]).
fSyndromic management consists of a questionnaire for symptoms of gonorrhea and chlamydia (i.e., vaginal discharge and other risk factors).
BP, blood pressure; PCR, polymerase chain reaction; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant; VIA, visual inspection with acetic acid.
doi:10.1371/journal.pmed.0030434.t002
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Packaging Health Servicespersonnel constraints), the less intensive strategy for cervical
cancer was chosen (visual inspection with acetic acid), and
treatment for depression was excluded, allowing for the
adoption of other interventions, such as blood pressure
screening for CVD in AFR-D,E and SEAR-D, and clinical
breast examination in AMR-D and EMR-D. When we
restricted only specialized personnel, a particularly scarce
resource in developing country settings (results on budget and
50% specialized personnel time), the less intensive strategy for
cervical cancer was again chosen. Because we assumed that
there would be no shortage of general personnel in this
scenario, one of the intervention options for depression was
selected in each of the four regions; although CVD inter-
ventions met the personnel time requirements, they exceeded
the budget constraint. For the most part, iron supplementa-
tion for all women was chosen as part of the package under
this scenario, as well as the other two scenarios.
Figure 2 speciﬁes the order in which interventions are
added (or substituted) for the particular budget of $75 per
woman in AFR-D,E. The introduction of personnel time
constraints results in the adoption of the less intensive
options for cervical cancer and CVD. The similarity of the
optimal package under both scenarios of personnel con-
straints suggests that the relative mix of general versus
specialized personnel has little inﬂuence on the package
itself. When the budget was increased to $100 per woman
(Figure 3), blood pressure screening for CVD was included
in all scenarios. The packages with personnel constraints
differed from the package that would be delivered with only
the budget constraint, and they produced lower overall
beneﬁts, primarily due to the adoption of the less intensive
option for cervical cancer. Furthermore, the type of
personnel constraint had a greater inﬂuence on the contents
of the package. When the budget was decreased to $50 per
woman (results not shown), the personnel time constraints
no longer inﬂuenced the contents of the package.
Discussion
In our simpliﬁed analysis, we considered packaging
interventions that may be delivered in a single contact in
order to maximize the potential burden of disease averted for
a relatively neglected segment of the population, subject to
two important resource constraints. We found that multiple
interventions were selected to be included in a package of
health services during a single cervical cancer screening visit.
When only a budget constraint was considered, these
interventions included treatment for depression, and screen-
ing or treatment for iron deﬁciency anemia and STDs (in two
regions). With the additional constraints on general and
specialized personnel, the contents of the optimal package
shifted and included the low-intensity intervention option
for cervical cancer, allowing for the inclusion of other
interventions in some regions, such as screening for breast
cancer and cardiovascular disease.
The goal of this analysis was to demonstrate an analytic
framework that can be used to explore potential advantages
of bundling interventions to be delivered in a single visit. We
encourage a shift from the traditional mindset of assessing
costs and beneﬁts of interventions for reducing mortality and
morbidity attributable to a single disease to exploring what
synergies might be achievable by thinking across disease
burdens.
Many countries, both developed and developing, have
explored the concept of packaging health services at select,
opportune moments in an individual’s life, such as the
perinatal period for both woman and child. The World Bank
Table 4. Results of IP Analysis: Package of Health Services under Constraints of Budget and Personnel Time
Targeted
Disease
Intervention Constraint: Budget Only
a Constraint: Budget and
All Personnel Time
a
Constraint: Budget and
Specialized Personnel Time
a
AFR-D,E AMR-D EMR-D SEAR-D AFR-D,E AMR-D EMR-D SEAR-D AFR-D,E AMR-D EMR-D SEAR-D
Breast cancer CBE 
Mammography
Cervical cancer VIA    
HPV DNA test   
CVD BP measurement  
Triple therapy
for all
Depression TCA 
SSRI     
Iron deficiency
anemia
Hemoglobin test 
Iron for all         
STDs Syndromic
management
PCR assay    
Total Costs, $
(Effects, DALYs
averted)
b
70
(0.0668)
74
(0.0916)
74
(0.0845)
70
(0.0819)
74
(0.0652)
63
(0.0708)
64
(0.0645)
75
(0.0741)
74
(0.0663)
66
(0.0769)
65
(0.0704)
75
(0.0791)
aBudget constraint was set at $75 per woman; personnel time constraint was set at 50% each.
bTotal costs and effects are per woman.
BP,bloodpressure;CBE,clinicalbreastexam;PCR,polymerasechainreaction;SSRI,selectiveserotoninreuptakeinhibitor;TCA,tricyclicantidepressant;VIA,visualinspectionusingaceticacid.
doi:10.1371/journal.pmed.0030434.t004
PLoS Medicine | www.plosmedicine.org November 2006 | Volume 3 | Issue 11 | e434 2035
Packaging Health Serviceshas identiﬁed as many as 18 countries that have made
attempts to design a package of essential health services,
citing 12 countries that have engaged in formal quantitative
analyses to inform these decisions, such as cost-effectiveness
analysis [12]. Our analysis differs from a cost-effectiveness
analysis in that we explicitly consider a human resource
constraint in addition to a monetary constraint. Other linear
programming models that have been used to optimize
resource allocation in the context of health have generally
considered only budget constraints [31–36].
Increasingly, decision makers are interested in constraints
such as specialized personnel [9–11] as well as affordability.
Our framework presents one method of formally and
explicitly taking into account nonmonetary constraints when
considering a package of services. The results from our
example suggest that the addition of personnel constraints
was inﬂuential under both budget limits. For example,
although human papillomavirus (HPV) DNA testing was the
preferred option for cervical cancer screening when only the
budget was considered, an alternative screening option with
fewer requirements for technical personnel was chosen when
we placed constraints speciﬁcally on the specialized person-
nel time. The selection of the simpler strategy actually then
allowed for the inclusion of interventions for other diseases,
such as screening and treatment for CVD and breast cancer.
Although a stylized example, this particular result provides
insight into the potential value of investments in rapid and
simple diagnostics for developing countries, such as the rapid
HPV test [37].
There are several limitations to both our analytic frame-
work and stylized example. First, we did not incorporate
every potential advantage of packaging services. Since we did
not include transportation costs, the potential travel-related
savings from avoiding multiple visits were not included. We
also did not include all shared resources among interven-
tions. There may be as-yet unidentiﬁed negative consequen-
ces of packaging, and these were also not included [38]. We
did not consider other constraints that may be inﬂuential
(e.g., facilities, roads, infrastructure); however, the analytic
framework ﬂexibly allows for future analyses to include such
resource requirements.
In our simpliﬁed example, we focused on a narrow group
of health conditions and interventions and examined a
limited range of budget and personnel constraints. Although
inﬁnite sets of diseases and interventions, and of budget and
personnel constraints, are possible, we arbitrarily chose the
current set to identify and illustrate key themes. For a
particular country wishing to employ these methods to
inform local decision making, in addition to identifying the
relevant nonmonetary constraints for their setting, they may
choose a predeﬁned set of criteria to select the candidate
diseases and interventions. Further, the DALY is only one
metric of health outcomes, and limitations in the methods
and data underlying the calculations of DALYs have been
discussed elsewhere [39,40]; in future analyses, alternative
measures of health outcomes, such as life expectancy, may be
reﬂected.
Our choice to present the speciﬁc example as a pedagogical
tool to demonstrate the use of these methods—rather than as
a policy analysis—reﬂects the importance we place on
explicitly acknowledging the data limitations. For this
example there were substantial data gaps for effectiveness,
costs, and personnel time estimates associated with all
interventions, and therefore simplifying assumptions were
Figure 2. Packages of Interventions under a Lifetime Budget of $75 per Woman in AFR-D,E
Each curve shows the order in which interventions are added (or substituted) when the budget is set at $75 per woman under the different scenarios of
personnel time constraints: no personnel time constraints (blue), 50% constraint on specialized personnel time only (pink), and 50% constraint on both
general and specialized personnel time (green). Curves in gray represent data from alternative lifetime budget set at $100 per woman (Figure 3). The
dotted line represents the budget constraint.
doi: 10.1371/journal.pmed.0030434.g002
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Packaging Health Servicesnecessary. Even when estimates of efﬁcacy were available, the
studies from which they were extrapolated were conducted
mainly in developed country settings, and for some variables
(e.g., treatment efﬁcacy) a good deal of uncertainty and
variability among studies existed. For our example, we
synthesized the best available data from multiple sources in
the literature in order to demonstrate how the framework
can be applied to a particular problem. A notable advantage
of the model is that for future analyses, model parameters can
easily be contextualized with country-speciﬁc data.
These methods provide a framework to enhance a decision
maker’s ability to simultaneously consider costs, beneﬁts, and
important nonmonetary constraints. We encourage a shift
from the traditional mindset of assesing costs and beneﬁts of
interventions that reduce mortality and morbidity attribut-
able to a single disease to exploring what synergies might be
achievable by thinking across disease burdens. As illustrated
by our simpliﬁed example, the packaging of multiple health
services during a one-time visit has the potential to increase
health gains, and constraints such as specialized personnel
shortages have the potential to inﬂuence the contents of the
package. With the mobilization of health services for
conditions such as cervical cancer, AIDS, tuberculosis, and
malaria [14], this framework has real-world relevance and can
be applied to multiple situations to leverage the contact
between the health care system and those with limited
opportunities to receive health care.
Supporting Information
Text S1. Technical Appendix
Found at DOI: 10.1371/journal.pmed.0030434.sd001 (558 KB DOC)
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Editors’ Summary
Background. Public health decision makers in developed and develop-
ing countries are exploring the idea of providing packages of health
checks at specific times during a person’s lifetime to detect and/or
prevent life-threatening diseases such as diabetes, heart problems, and
some cancers. Bundling together tests for different diseases has
advantages for both health-care systems and patients. It can save time
and money for both parties and, by associating health checks with life
events such as childbirth, it can take advantage of a valuable opportunity
to check on the overall health of individuals who may otherwise rarely
visit a doctor. But money and other resources (for example, nurses to
measure blood pressure) are always limited, even in wealthy countries,
so decision makers have to assess the likely costs and benefits of
packages of interventions before putting them into action.
Why Was This Study Done? Recent evidence suggests that women in
developing countries would benefit from a once-in-a-lifetime screen for
cervical cancer, a leading cause of cancer death for this population. If
such a screening strategy for cervical cancer were introduced, it might
provide a good opportunity to offer women other health checks, but it is
unclear which interventions should be packaged together. In this study,
the researchers have developed an analytic framework to identify an
optimal package of health services to offer to women attending a clinic
for their lifetime cervical cancer screen. Their model takes into account
monetary limitations and possible shortages in trained personnel to do
the health checks, and balances these constraints against the likely
health benefits for the women.
What Did the Researchers Do and Find? The researchers developed a
‘‘mathematical programming’’ model to identify an optimal package of
health services to be provided during a single visit. They then used their
model to estimate the average costs and health outcomes per woman of
various combinations of health interventions for 35- to 40-year-old
women living in four regions of the worldwith high adult death rates. The
researchers chose breast cancer, cardiovascular disease, depression,
anemia caused by iron deficiency, and sexually transmitted diseases as
health conditions to be checked in addition to cervical cancer during the
singlevisit.Theyconsideredtwoways—onecheapin termsofmoneyand
people; the other more expensive but often more effective—of checking
forordealingwitheachpotentialhealthproblem.Whentheysetarealistic
budgetary constraint (based on the annual health budget of the poorest
countries and a single health check per woman in the two decades
following her reproductive years), the optimal health package generated
by the model for all four regions included cervical cancer screening done
by testing for human papillomavirus (an effective but complex test),
treatment for depression, and screening or treatment for anemia. When a
50% shortage in general (for example, nurses) and specialized (for
example,doctors)personneltimewasalsoincluded,thehealthbenefitsof
the package were maximized by using a simpler test for cervical cancer
and by treating anemia but not depression; this freed up resources in
some regions to screen for breast cancer or cardiovascular disease.
What Do These Findings Mean? The model described by the
researchers provides a way to explore the potential advantages of
delivering a package of health interventions to individuals in a single
visit. Like all mathematical models, its conclusions rely heavily on the
data used in its construction. Indeed, the researchers stress that, because
they did not have full data on the effectiveness of each intervention and
made many other assumptions, their results on their own cannot be
used to make policy decisions. Nevertheless, their results clearly show
that the packaging of multiple health services during a single visit has
great potential to maximize health gains, provided the right interven-
tions are chosen. Most importantly, their analysis shows that in the real
world the shortage of personnel, which has been ignored in previous
analyses even though it is a major problem in many developing
countries, will affect which health conditions and specific interventions
should be bundled together to provide the greatest impact on public
health.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0030434.g001.
 The World Health Organization has information on choosing
cost-effective health interventions and on human resources for health
 The American Cancer Society offers patient information on cervical
cancer
 The Alliance for Cervical Cancer Prevention includes information about
cervical cancer prevention programs in developing countries
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